News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HENWOOD GERALDINE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/20/2020 |
4/A
| HENWOOD GERALDINE (President and CEO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Sold 80,000 shares
@ $8.22, valued at
$657.6k
Exercised 80,000 options to buy
@ $2.47, valued at
$197.6k
|
|
| 02/19/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/28/2015 |
4/A
| HENWOOD GERALDINE (President and CEO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 123,500 options to buy
@ $2.47, valued at
$305k
Granted 123,500 options to buy
@ $2.47, valued at
$305k
|
|
| 06/26/2015 |
4/A
| HENWOOD GERALDINE (President and CEO) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 123,500 options to buy
@ $2.47, valued at
$305k
|
|
|
|